TrialClinical and vaccine immunology : CVI2012

Phase IIa study of the immunogenicity and safety of the novel Staphylococcus aureus vaccine V710 in adults with end-stage renal disease receiving hemodialysis.

Moustafa Moustafa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.